Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01219699
Title A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals

estrogen-receptor positive breast cancer

Advanced Solid Tumor



Alpelisib + Fulvestrant

Age Groups: senior | adult
Covered Countries USA | ESP | DEU

Additional content available in CKB BOOST